Literature DB >> 9193962

Methodological issues in characterizing treatment response in demented patients with behavioral disturbances.

B H Mulsant1, S Mazumdar, B G Pollock, R A Sweet, J Rosen, K Lo.   

Abstract

Despite the proliferation of instruments developed to rate behavioral disturbances associated with dementia, systematic studies of how ratings on these instruments should be analyzed to measure change in disruptive behaviors or distressing symptoms (ie treatment response) are noticeably absent. Using one of these scales, we compared three methods to characterize treatment response in 52 elderly demented inpatients who participated in a standardized neuroleptic trial. While all three analyses identified a statistically significant improvement, they conveyed differently the clinical improvement experienced by the patients. Categorical outcomes communicated the clinical meaning of improvement better than changes in total score; changes in factor scores best revealed the differential impact of treatment on specific behavioral and symptomatic domains. Given the heterogeneity of the problematic behaviors and symptoms exhibited by demented patients included in treatment trials, regardless of the intervention being tested or of the instrument being used to rate behaviors, a focused approach to characterizing treatment response is needed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9193962

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  The neurobehavioural rating scale-revised: sensitivity and validity in closed head injury assessment.

Authors:  S R McCauley; H S Levin; M Vanier; J M Mazaux; C Boake; P R Goldfader; D Rockers; M Butters; D A Kareken; J Lambert; G L Clifton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

2.  Citalopram for agitation in Alzheimer's disease: design and methods.

Authors:  Lea T Drye; Zahinoor Ismail; Anton P Porsteinsson; Paul B Rosenberg; Daniel Weintraub; Christopher Marano; Gregory Pelton; Constantine Frangakis; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; D P Devanand; Jerome Yesavage; Jacobo E Mintzer; Lon S Schneider; Bruce G Pollock; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

3.  Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

4.  A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.

Authors:  Zahinoor Ismail; Chetachi A Emeremni; Patricia R Houck; Sati Mazumdar; Jules Rosen; Tarek K Rajji; Bruce G Pollock; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

5.  The role of antipsychotics in treating delirium.

Authors:  Larry Tune
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

6.  Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.

Authors:  Alexandre Y Dombrovski; Benoit H Mulsant; Robert E Ferrell; Francis E Lotrich; Jules I Rosen; Meredith Wallace; Patricia R Houck; Sati Mazumdar; Bruce G Pollock
Journal:  Int Clin Psychopharmacol       Date:  2010-01       Impact factor: 1.659

7.  Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention.

Authors:  Laura N Gitlin; Laraine Winter; Marie P Dennis; Nancy Hodgson; Walter W Hauck
Journal:  J Am Geriatr Soc       Date:  2010-07-19       Impact factor: 5.562

8.  Preventing late-life depression in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

9.  Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis.

Authors:  Noll Campbell; Amir Ayub; Malaz A Boustani; Chris Fox; Martin Farlow; Ian Maidment; Robert Howards
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: design and methods of project ACT3.

Authors:  Laura N Gitlin; Laraine Winter; Marie P Dennis; Walter W Hauck
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.